- Release Date: 31/05/23 08:40
- Summary: Corporate Presentation - Staged Development Strategy
- Price Sensitive: No
- Download Document 8.77MB
- Forums
- ASX - By Stock
- Ann: Corporate Presentation - Staged Development Strategy
HAS
hastings technology metals ltd
Add to My Watchlist
5.26%
!
27.0¢

Ann: Corporate Presentation - Staged Development Strategy
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.0¢ |
Change
-0.015(5.26%) |
Mkt cap ! $50.99M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 27.0¢ | $22.24K | 81.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3803 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 4982 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3703 | 0.270 |
5 | 41792 | 0.265 |
6 | 40583 | 0.260 |
6 | 63113 | 0.255 |
8 | 70000 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 982 | 3 |
0.280 | 892 | 1 |
0.290 | 212156 | 3 |
0.295 | 38815 | 2 |
0.300 | 22000 | 3 |
Last trade - 15.06pm 04/07/2025 (20 minute delay) ? |
Featured News
HAS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online